Skip to main content
TipRanks
Go Ultimate75% OFF

Regen Biopharma (RGBP) Financial Statements

122 Followers

Regen Biopharma Financial Overview

Regen Biopharma's market cap is currently $202.92K. The company's EPS TTM is $-0.02; its P/E ratio is -0.01; Regen Biopharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Sep 25Sep 24Sep 23Sep 22Sep 21
Income Statement
Total Revenue$ 236.56K$ 236.56K$ 236.56K$ 235.52K$ 171.19K
Gross Profit$ 236.56K$ 236.56K$ 236.56K$ 185.52K$ 146.19K
Operating Income$ -338.54K$ -417.00K$ -687.00K$ -340.00K$ -201.00K
EBITDA$ -1.01M$ -418.00K$ 1.22M$ 2.77M$ -6.35M
Net Income$ -1.27M$ -668.00K$ 1.02M$ 2.23M$ -6.76M
Balance Sheet
Cash & Short-Term Investments$ 716.00$ 716.00$ 121.04K$ 51.20K$ 727.16K
Total Assets$ 274.63K$ 177.61K$ 353.62K$ 559.00K$ 1.21M
Total Debt$ 793.70K$ 814.70K$ 756.20K$ 1.27M$ 3.58M
Net Debt$ 792.98K$ 813.98K$ 635.17K$ 1.22M$ 2.86M
Total Liabilities$ 6.56M$ 5.37M$ 5.46M$ 8.60M$ 14.70M
Stockholders' Equity$ -6.28M$ -5.19M$ -5.10M$ -8.04M$ -13.49M
Cash Flow
Free Cash Flow$ -383.59K$ -693.14K$ -173.92K$ -606.92K$ -1.13M
Operating Cash Flow$ -383.59K$ -693.14K$ -173.92K$ -606.92K$ -1.13M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 25.00K$ 495.00K
Financing Cash Flow$ 452.43K$ 572.82K$ 243.75K$ -94.04K$ 1.36M

Currency in USD

Regen Biopharma Earnings and Revenue History

-8M-4M04M-6000 %-3000 %0 %3000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Regen Biopharma Liabilities to Assets

06M12M18M0 %4000 %8000 %12000 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Regen Biopharma Cash Flow

-3M-2M-1M01M2M3M201720182019202020212022202320242025OperatingInvestingFinancing

Regen Biopharma Forecast EPS vs Actual EPS

0Q2 18EPS EstimateBeatMiss